Marika Pohjanoksa-Mäntylä
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Marika Pohjanoksa-Mäntylä has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Marja Airaksinen
Clinical Pharmacy Group, Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland
3 shared publications J. Simon Bell
Division of Social Pharmacy, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland
2 shared publicationsMarianne Enäkoski
Pihtipudas Pharmacy, Pihtipudas, Finland
2 shared publicationsMarja S. Airaksinen
Division of Social Pharmacy, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland
2 shared publicationsUlla Närhi
Department for Social and Health Services, Ministry of Social Affairs and Health, Helsinki, Finland
2 shared publicationsA. Karjalainen
National Agency for Medicines, Helsinki, Finland
1 shared publication
Latest Publications
- Open Access
- 6 June 2026
- Published by Elsevier in International Journal of Drug Policy
- Vol. 155, 105380
Psychoactive drug use among athletes: motives and risk factors beyond sports performance – A scoping review
- 6 June 2026
- Published by Elsevier in International Journal of Drug Policy
- Vol. 155, 105380
Open AccessPsychoactive drug use among athletes: motives and risk factors beyond sports performance – A scoping review
- Open Access
- 14 March 2023
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 20 (6) , 5079
Developing Medication Review Competency in Undergraduate Pharmacy Training: A Self-Assessment by Third-Year Students
Pharmacists are increasingly involved in medication history taking, medication reconciliation, and review in their daily practice. The objectives of this study were to investigate third-year pharmacy students’ self-assessed competency in medication reviews and gather their feedback for further development of medication review training in their curriculum. The study was conducted as a self-assessment of third-year pharmacy students at the completion of their second three-month internship period in a community pharmacy in 2017–2018. The students were assigned to review medications of a real patient under the supervision of a medication review accredited pharmacist during their internship. The self-assessment was carried out via an e-form, which was created for this study. Recently established national medication review competence recommendations for pharmacists were used as a reference. Students (n = 95, participation rate: 93%) self-assessed their competency as good or very good in 91% (n = 28) of the competency areas listed in the self-assessment. The highest proportion of competencies that were self-assessed as good or very good included using medication risk management databases and evaluating the clinical importance of the information (97%, n = 92). The lowest proportion of competencies was found in applying clinical information from the key laboratory tests to patient care and knowing which laboratory tests are most important to monitor in each condition and medication (36%, n = 34). The students suggested that their pharmacy education should contain more medication review assignments as group work and that an elective course on medication reviews should be compulsory for all pharmacy students.
- 14 March 2023
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 20 (6) , 5079
Open AccessDeveloping Medication Review Competency in Undergraduate Pharmacy Training: A Self-Assessment by Third-Year Students
Pharmacists are increasingly involved in medication history taking, medication reconciliation, and review in their daily practice. The objectives of this study were to investigate third-year pharmacy students’ self-assessed competency in medication reviews and gather their feedback for further development of medication review training in their curriculum. The study was conducted as a self-assessment of third-year pharmacy students at the completion of their second three-month internship period in a community pharmacy in 2017–2018. The students were assigned to review medications of a real patient under the supervision of a medication review accredited pharmacist during their internship. The self-assessment was carried out via an e-form, which was created for this study. Recently established national medication review competence recommendations for pharmacists were used as a reference. Students (n = 95, participation rate: 93%) self-assessed their competency as good or very good in 91% (n = 28) of the competency areas listed in the self-assessment. The highest proportion of competencies that were self-assessed as good or very good included using medication risk management databases and evaluating the clinical importance of the information (97%, n = 92). The lowest proportion of competencies was found in applying clinical information from the key laboratory tests to patient care and knowing which laboratory tests are most important to monitor in each condition and medication (36%, n = 34). The students suggested that their pharmacy education should contain more medication review assignments as group work and that an elective course on medication reviews should be compulsory for all pharmacy students.
- Open Access
- 5 November 2020
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 17 (21) , 8186
Medication Risk Management in Routine Dispensing in Community Pharmacies
Community pharmacists have a duty to contribute to medication risk management in outpatient care. This study aimed to investigate the actions taken by pharmacists in routine dispensing to manage medication risks. The study was conducted as a national cross-sectional online survey targeted at all community pharmacies in Finland (n = 576) in October 2015. One pharmacist from each pharmacy was recommended to be the spokesperson for the outlet to describe their practices. Responses were received from 169 pharmacies (response rate of 29%). Pharmacists were oriented to solving poor adherence and technical problems in prescriptions, whereas responsibility for therapeutic risks was transferred to the patient to resolve them with the physician. Pharmacists have access to a wide range of electronic medication risk management tools, but they are rarely utilized in daily dispensing. Attention was paid to drug–drug interactions and the frequency of dispensing with regard to high-risk medicines. Pharmacies rarely had local agreements with other healthcare providers to solve medication-related risks. In routine dispensing, more attention needs to be given to the identification and solving of therapeutic risks in medications, especially those of older adults. Better participation of community pharmacists in medication risk management requires stronger integration and an explicit mandate to solve the therapeutic risks.
- 5 November 2020
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 17 (21) , 8186
Open AccessMedication Risk Management in Routine Dispensing in Community Pharmacies
Community pharmacists have a duty to contribute to medication risk management in outpatient care. This study aimed to investigate the actions taken by pharmacists in routine dispensing to manage medication risks. The study was conducted as a national cross-sectional online survey targeted at all community pharmacies in Finland (n = 576) in October 2015. One pharmacist from each pharmacy was recommended to be the spokesperson for the outlet to describe their practices. Responses were received from 169 pharmacies (response rate of 29%). Pharmacists were oriented to solving poor adherence and technical problems in prescriptions, whereas responsibility for therapeutic risks was transferred to the patient to resolve them with the physician. Pharmacists have access to a wide range of electronic medication risk management tools, but they are rarely utilized in daily dispensing. Attention was paid to drug–drug interactions and the frequency of dispensing with regard to high-risk medicines. Pharmacies rarely had local agreements with other healthcare providers to solve medication-related risks. In routine dispensing, more attention needs to be given to the identification and solving of therapeutic risks in medications, especially those of older adults. Better participation of community pharmacists in medication risk management requires stronger integration and an explicit mandate to solve the therapeutic risks.
- 1 July 2019
- Published by Elsevier in Research in Social and Administrative Pharmacy
- Vol. 15 (7) , 811-812
Improving medication safety in varied health systems
- 1 July 2019
- Published by Elsevier in Research in Social and Administrative Pharmacy
- Vol. 15 (7) , 811-812
Improving medication safety in varied health systems
- 1 August 2018
- Published by Elsevier in Currents in Pharmacy Teaching and Learning
- Vol. 10 (8) , 1041-1047
Use and accessibility of health and medication information sources among pharmacy students during their community pharmacy internship
- 1 August 2018
- Published by Elsevier in Currents in Pharmacy Teaching and Learning
- Vol. 10 (8) , 1041-1047
Use and accessibility of health and medication information sources among pharmacy students during their community pharmacy internship
- 12 March 2010
- Published by Springer Nature in Social Psychiatry and Psychiatric Epidemiology
- Vol. 46 (5) , 373-379
Is the Internet replacing health professionals? A population survey on sources of medicines information among people with mental disorders
Background People with mental disorders often report unmet medicine information needs and may search for information on medicines from sources including the Internet, telephone services, books and other written materials. Objective This study aimed to identify and describe the sources of medicines information used by people with and without mental disorders. Methods A cross sectional postal survey was mailed to a nationally representative sample (n = 5,000) of Finns aged 15–64 years in spring 2005. Completed responses were received from 3,287 people (response rate 66%), of whom 2,348 reported using one or more sources of medicines information during the past 12 months. Of those who reported one or more sources of medicines information, 10% (n = 228) reported being diagnosed with or treated for a mental disorder. The main outcome measures were the sources of medicines information used by people who did and did not report being diagnosed with or treated for a mental disorder. Results Among respondents with and without a mental disorder, physicians (83 vs. 59%), pharmacists (56 vs. 49%) and patient information leaflets (53 vs. 43%) were the most common sources of medicines information. After adjusting for age, gender, level of education, working status and number of chronic diseases, respondents with mental disorders were more likely to use patient information leaflets (OR 1.47, 95% CI 1.06–1.98) and the Internet (OR 1.64, 95% CI 1.02–2.64) as sources of medicines information than respondents without mental disorders. Conclusions The results indicate that physicians and pharmacists are the most common sources of medicines information among people both with and without mental disorders. However, patient information leaflets and the Internet were more commonly used by people with mental disorders. There may be an opportunity for clinicians to better exploit these sources of medicines information when developing medicines information services for people with mental disorders.
- 12 March 2010
- Published by Springer Nature in Social Psychiatry and Psychiatric Epidemiology
- Vol. 46 (5) , 373-379
Is the Internet replacing health professionals? A population survey on sources of medicines information among people with mental disorders
Background People with mental disorders often report unmet medicine information needs and may search for information on medicines from sources including the Internet, telephone services, books and other written materials. Objective This study aimed to identify and describe the sources of medicines information used by people with and without mental disorders. Methods A cross sectional postal survey was mailed to a nationally representative sample (n = 5,000) of Finns aged 15–64 years in spring 2005. Completed responses were received from 3,287 people (response rate 66%), of whom 2,348 reported using one or more sources of medicines information during the past 12 months. Of those who reported one or more sources of medicines information, 10% (n = 228) reported being diagnosed with or treated for a mental disorder. The main outcome measures were the sources of medicines information used by people who did and did not report being diagnosed with or treated for a mental disorder. Results Among respondents with and without a mental disorder, physicians (83 vs. 59%), pharmacists (56 vs. 49%) and patient information leaflets (53 vs. 43%) were the most common sources of medicines information. After adjusting for age, gender, level of education, working status and number of chronic diseases, respondents with mental disorders were more likely to use patient information leaflets (OR 1.47, 95% CI 1.06–1.98) and the Internet (OR 1.64, 95% CI 1.02–2.64) as sources of medicines information than respondents without mental disorders. Conclusions The results indicate that physicians and pharmacists are the most common sources of medicines information among people both with and without mental disorders. However, patient information leaflets and the Internet were more commonly used by people with mental disorders. There may be an opportunity for clinicians to better exploit these sources of medicines information when developing medicines information services for people with mental disorders.
- 30 April 2009
- Published by Elsevier in Journal of Affective Disorders
- Vol. 114 (1-3) , 333-339
How and why do people with depression access and utilize online drug information: A qualitative study
- 30 April 2009
- Published by Elsevier in Journal of Affective Disorders
- Vol. 114 (1-3) , 333-339
How and why do people with depression access and utilize online drug information: A qualitative study
- 18 November 2008
- Published by SAGE Publications in Annals of Pharmacotherapy
- Vol. 42 (12) , 1782-1790
Email Medication Counseling Services Provided by Finnish Community Pharmacies
Background: The importance of email as a mode of communication between medication users and pharmacists is likely to increase. However, little is known about the email medication counseling practices of community pharmacies. Objective: To determine the prevalence of email medication counseling services in Finland and to assess the accuracy and comprehensiveness of responses by pharmacies providing the opportunity for email medication counseling to inquiries related to use of antidepressants. Methods: An inventory was made of all Finnish community pharmacies that provided the opportunity for email medication counseling. Data related to the accuracy and comprehensiveness of responses were collected, using a virtual pseudo-customer method with 3 scenarios related to common concerns of patients on antidepressants. Two inquiries were emailed to each pharmacy that provided the opportunity for email medication counseling in January and February 2005. The responses were content analyzed by 2 researchers, using a prestructured scoring system. Results: Almost one-third (30%, n = 182) of Finnish community pharmacies maintained a working Web site, and 94% of those provided the opportunity for email medication counseling. An online “ask-the-pharmacist” service was offered by 13% (n = 23) of the pharmacies with a Web site. Pharmacies responded to 54% of the email inquiries sent by the virtual pseudo-customers. The response rate and the content score ratio between mean and maximum scores varied among the scenarios. The content score ratio was highest for the scenarios concerning the adverse effects of fluoxetine (0.53, n = 55) and interactions with mirtazapine (0.52, n = 63) and lowest for the scenario related to sexual dysfunction and weight gain associated with citalopram (0.38, n = 52). Conclusions: Community pharmacies are potential providers of email medication counseling services. However, more attention should be directed to responding to consumer inquiries and to the content of these responses.
- 18 November 2008
- Published by SAGE Publications in Annals of Pharmacotherapy
- Vol. 42 (12) , 1782-1790
Email Medication Counseling Services Provided by Finnish Community Pharmacies
Background: The importance of email as a mode of communication between medication users and pharmacists is likely to increase. However, little is known about the email medication counseling practices of community pharmacies. Objective: To determine the prevalence of email medication counseling services in Finland and to assess the accuracy and comprehensiveness of responses by pharmacies providing the opportunity for email medication counseling to inquiries related to use of antidepressants. Methods: An inventory was made of all Finnish community pharmacies that provided the opportunity for email medication counseling. Data related to the accuracy and comprehensiveness of responses were collected, using a virtual pseudo-customer method with 3 scenarios related to common concerns of patients on antidepressants. Two inquiries were emailed to each pharmacy that provided the opportunity for email medication counseling in January and February 2005. The responses were content analyzed by 2 researchers, using a prestructured scoring system. Results: Almost one-third (30%, n = 182) of Finnish community pharmacies maintained a working Web site, and 94% of those provided the opportunity for email medication counseling. An online “ask-the-pharmacist” service was offered by 13% (n = 23) of the pharmacies with a Web site. Pharmacies responded to 54% of the email inquiries sent by the virtual pseudo-customers. The response rate and the content score ratio between mean and maximum scores varied among the scenarios. The content score ratio was highest for the scenarios concerning the adverse effects of fluoxetine (0.53, n = 55) and interactions with mirtazapine (0.52, n = 63) and lowest for the scenario related to sexual dysfunction and weight gain associated with citalopram (0.38, n = 52). Conclusions: Community pharmacies are potential providers of email medication counseling services. However, more attention should be directed to responding to consumer inquiries and to the content of these responses.
- 1 June 2008
- Published by Elsevier in Research in Social and Administrative Pharmacy
- Vol. 4 (2) , 144-152
Utilization of a community pharmacy-operated national drug information call center in Finland
- 1 June 2008
- Published by Elsevier in Research in Social and Administrative Pharmacy
- Vol. 4 (2) , 144-152
Utilization of a community pharmacy-operated national drug information call center in Finland
- 30 September 2007
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 32 (1) , S16-S17
How and why people use the internet to access information about antidepressant medicines
- 30 September 2007
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 32 (1) , S16-S17
How and why people use the internet to access information about antidepressant medicines